Pain induced by calcineurin inhibitors is a rare complication of unknown pathogenesis. We have reported herein a 7-year-old child who presented with abdominal pain, vomiting, and weight loss showing no significant findings after an extensive laboratory and imaging workup. After conversion from tacrolimus to sirolimus, there was complete resolution of the gastrointestinal symptoms and pain; the patient displays excellent renal function. Calcineurin inhibitor-induced pain syndrome is diagnosis of exclusion but must be considered because the withdrawal of this immunosuppressive agent is associated with improvement in symptoms and quality of life.Univ Estadual Campinas, Dept Pediat, Discipline Pediat Nephrol, São Paulo, BrazilWeb of Scienc
BACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, transplant patients treated with...
Sirolimus, a macrocylic lactone, blocks T-cell activation by a mechanism of action distinct from cal...
Item does not contain fulltextBACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, tr...
Introduction: Kidney transplant is the first-line therapy for chronic kidney disease. Immunosuppress...
Context: Musculoskeletal pain is a frequent manifestation in postrenal transplant recipients that ca...
Setting: University Hospital Patient: 65-year-old female status-post liver transplant secondary to c...
This article is made available for unrestricted research re-use and secondary analysis in any form o...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Calcineurin inhibitors (CNIs) are typically used to prevent organ rejection and their use has signif...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Pain syndrome with stress fractures in transplanted patients treated with calcineurin inhibitor
BACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, transplant patients treated with...
Sirolimus, a macrocylic lactone, blocks T-cell activation by a mechanism of action distinct from cal...
Item does not contain fulltextBACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, tr...
Introduction: Kidney transplant is the first-line therapy for chronic kidney disease. Immunosuppress...
Context: Musculoskeletal pain is a frequent manifestation in postrenal transplant recipients that ca...
Setting: University Hospital Patient: 65-year-old female status-post liver transplant secondary to c...
This article is made available for unrestricted research re-use and secondary analysis in any form o...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Calcineurin inhibitors (CNIs) are typically used to prevent organ rejection and their use has signif...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Nephrotoxicity caused by calcineurin inhibitors can lead to either delayed graft function or long-te...
Pain syndrome with stress fractures in transplanted patients treated with calcineurin inhibitor
BACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, transplant patients treated with...
Sirolimus, a macrocylic lactone, blocks T-cell activation by a mechanism of action distinct from cal...
Item does not contain fulltextBACKGROUND: In an attempt to reduce calcineurin inhibitor toxicity, tr...